Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Operating Leases (2020 - 2025)

Historic Operating Leases for Korro Bio (KRRO) over the last 6 years, with Q3 2025 value amounting to $44.7 million.

  • Korro Bio's Operating Leases rose 689.96% to $44.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 689.96%. This contributed to the annual value of $43.5 million for FY2024, which is 3929.07% up from last year.
  • As of Q3 2025, Korro Bio's Operating Leases stood at $44.7 million, which was up 689.96% from $44.6 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Operating Leases registered a high of $45.2 million during Q1 2025, and its lowest value of $209000.0 during Q4 2022.
  • In the last 5 years, Korro Bio's Operating Leases had a median value of $30.0 million in 2021 and averaged $32.1 million.
  • Per our database at Business Quant, Korro Bio's Operating Leases crashed by 9927.56% in 2022 and then soared by 1483588.52% in 2023.
  • Korro Bio's Operating Leases (Quarter) stood at $28.9 million in 2021, then plummeted by 99.28% to $209000.0 in 2022, then skyrocketed by 14835.89% to $31.2 million in 2023, then surged by 39.29% to $43.5 million in 2024, then rose by 2.73% to $44.7 million in 2025.
  • Its Operating Leases stands at $44.7 million for Q3 2025, versus $44.6 million for Q2 2025 and $45.2 million for Q1 2025.